UA86411U - Method for preventing progression of pathological alterations in blood circulation in patients with bronchial asthma - Google Patents

Method for preventing progression of pathological alterations in blood circulation in patients with bronchial asthma

Info

Publication number
UA86411U
UA86411U UAU201309018U UAU201309018U UA86411U UA 86411 U UA86411 U UA 86411U UA U201309018 U UAU201309018 U UA U201309018U UA U201309018 U UAU201309018 U UA U201309018U UA 86411 U UA86411 U UA 86411U
Authority
UA
Ukraine
Prior art keywords
patients
blood circulation
bronchial asthma
pathological alterations
preventing progression
Prior art date
Application number
UAU201309018U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Юрий Иванович Фещенко
Наталья Владимировна Пархоменко
Наталья Андреевна Примушко
Людмила Владимировна Ролик
Жанна Борисовна Бегоулева
Леся Михайловна Курик
Инна Петровна Турчина
Александр Игоревич Адамчук
Евгения Александровна Меренкова
Елена Игоревна Адамчук
Мирослав Богданович Сингаевский
Original Assignee
Государственное Учреждение "Национальный Институт Фтизиатрии И Пульмонологии Им. Ф.Г. Яновского Национальной Академии Медицинских Наук Украины"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Национальный Институт Фтизиатрии И Пульмонологии Им. Ф.Г. Яновского Национальной Академии Медицинских Наук Украины" filed Critical Государственное Учреждение "Национальный Институт Фтизиатрии И Пульмонологии Им. Ф.Г. Яновского Национальной Академии Медицинских Наук Украины"
Priority to UAU201309018U priority Critical patent/UA86411U/en
Publication of UA86411U publication Critical patent/UA86411U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The method for preventing the progression of pathological alterations in blood circulation in the patients with bronchial asthma comprises the use of inhalation corticosteroid and β-agonist of short action. Upon completion of the treatment course, the oral drug containing ginkgolids and bilobalids is provided.
UAU201309018U 2013-07-18 2013-07-18 Method for preventing progression of pathological alterations in blood circulation in patients with bronchial asthma UA86411U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201309018U UA86411U (en) 2013-07-18 2013-07-18 Method for preventing progression of pathological alterations in blood circulation in patients with bronchial asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201309018U UA86411U (en) 2013-07-18 2013-07-18 Method for preventing progression of pathological alterations in blood circulation in patients with bronchial asthma

Publications (1)

Publication Number Publication Date
UA86411U true UA86411U (en) 2013-12-25

Family

ID=52286083

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201309018U UA86411U (en) 2013-07-18 2013-07-18 Method for preventing progression of pathological alterations in blood circulation in patients with bronchial asthma

Country Status (1)

Country Link
UA (1) UA86411U (en)

Similar Documents

Publication Publication Date Title
PH12017502154A1 (en) Methods for conditioning patients for t cell therapy
MX2017014338A (en) Targeted selection of patients for treatment with cortistatin derivatives.
HK1217088A1 (en) Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
EP3156081A4 (en) Cell structure for use in treatment of brain injury, method for producing same, and therapeutic agent for brain injury
MX2016005159A (en) Methods of diagnosing and treating eosinophilic disorders.
MY174727A (en) Stable, protracted glp-1/glucagon receptor co-agonists for medical use
MX2015007714A (en) Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective.
EP2875158A4 (en) Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
IN2015DN00450A (en)
MX2015012322A (en) Use of levocetirizine and montelukast in the treatment of autoimmune disorders.
PT3087178T (en) Method for producing oxalate oxidases having activity optimum near physiological ph and use of such recombinant oxalate oxidases in the treatment of oxalate-related diseases
MX2015012315A (en) Use of levocetirizine and montelukast in the treatment of traumatic injury.
MX2015011905A (en) Use of levocetirizine and montelukast in the treatment of vasculitis.
PH12016500863A1 (en) Tetracyclic autotaxin inhibitors
IL245738A0 (en) Oxindole derivatives, preparation thereof and therapeutic use in the treatment of ampk-related diseases
EP3253438A4 (en) Apparatus and methods for administering treatment within a bodily duct of a patient
MX2015011671A (en) Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis.
MX2023007706A (en) Nanoparticles for use as a therapeutic vaccine.
MX2015011775A (en) Use of levocetirizine and montelukast in the treatment of anaphylaxis.
HK1225441A1 (en) Method of treating and prognosing scoliotic patient subgroups
EP3644753A4 (en) Methods for maintaining and improving kidney function in patients with kidney disease and on standard of care therapy
GB201309645D0 (en) Treatment of peripheral arterial disease and other conditions, and apparatus therefor
UA86411U (en) Method for preventing progression of pathological alterations in blood circulation in patients with bronchial asthma
UA86898U (en) Method for treating vascular lesions of retina and optic nerve in patients with cerebral pathology
UA88769U (en) Method for preventing and treating benign breast dysplasia in patients with early miscarriage